February 19, 2014

Northera approved for rare blood pressure condition

(HealthDay)—Northera (droxidopa) has been approved by the U.S. Food and Drug Administration to treat a rare, chronic condition characterized by a sudden drop in blood pressure when a person stands.

Neurogenic orthostatic hypotension (NOH) is most often associated with Parkinson's disease and other neurologic disorders. Symptoms may include dizziness, lightheadedness, blurred vision, fatigue and fainting, the FDA said in a news release.

Granted accelerated approval to treat a rare condition, the drug will have a boxed label warning that it could cause an unhealthy rise in blood pressure while a person is lying down. This potential side effect could lead to a stroke, the agency said, warning that Northera users should be monitored carefully.

Other less serious side effects could include headache, dizziness, nausea, high blood pressure and fatigue, the FDA said.

Northera is produced by Chelsea Therapeutics, based in Charlotte, N.C.

More information: The FDA has more about this approval.

Citation: Northera approved for rare blood pressure condition (2014, February 19) retrieved 18 April 2024 from https://medicalxpress.com/news/2014-02-northera-rare-blood-pressure-condition.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Vimizim approved for rare childhood disorder

Feedback to editors

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

25 minutes ago

Scientists identify airway cells that sense aspirated water and acid reflux

25 minutes ago

Environment may influence metacognitive abilities more than genetics

38 minutes ago

Contracting RSV before age two can cause long-term lung changes and impairment

49 minutes ago

New therapy shows promise for a rare childhood dementia

1 hour ago

Mutations in noncoding DNA become functional in some cancer-driving genes

1 hour ago

Novel cell therapy treatments offer promise to immune-compromised children

1 hour ago

DNA vaccine against Zika performs well in tests on mice

1 hour ago

Human cases of bird flu 'an enormous concern': WHO

3 hours ago

Perfect balance: How the brain fine-tunes its sensitivity

3 hours ago

Load comments (0)

Northera approved for rare blood pressure condition

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

Scientists identify airway cells that sense aspirated water and acid reflux

Environment may influence metacognitive abilities more than genetics

Contracting RSV before age two can cause long-term lung changes and impairment

New therapy shows promise for a rare childhood dementia

Mutations in noncoding DNA become functional in some cancer-driving genes

Novel cell therapy treatments offer promise to immune-compromised children

DNA vaccine against Zika performs well in tests on mice

Human cases of bird flu 'an enormous concern': WHO

Perfect balance: How the brain fine-tunes its sensitivity

Vimizim approved for rare childhood disorder

Iclusig approved for rare leukemias

Adempas approved to treat pulmonary hypertension

Opsumit approved for pulmonary arterial hypertension

First non-hormonal remedy approved for menopausal hot flashes

Pomalyst approved for advanced multiple myeloma

Antipsychotics for dementia linked to more harms than previously acknowledged

Ketamine produces wide variety of responses in the brain, researchers find

Which treatments for malnutrition's long-term effects could help reduce mortality and health outcomes for children

New drug may slow rapid progression of Parkinson's disease

Large study finds antibiotics aren't effective for most lower tract respiratory infections

Epilepsy drug prevents brain tumors in mice with neurofibromatosis type 1

Phys.org

Tech Xplore

Science X

Northera approved for rare blood pressure condition

A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

Scientists identify airway cells that sense aspirated water and acid reflux

Environment may influence metacognitive abilities more than genetics

Contracting RSV before age two can cause long-term lung changes and impairment

New therapy shows promise for a rare childhood dementia

Mutations in noncoding DNA become functional in some cancer-driving genes

Novel cell therapy treatments offer promise to immune-compromised children

DNA vaccine against Zika performs well in tests on mice

Human cases of bird flu 'an enormous concern': WHO

Perfect balance: How the brain fine-tunes its sensitivity

Related Stories

Vimizim approved for rare childhood disorder

Iclusig approved for rare leukemias

Adempas approved to treat pulmonary hypertension

Opsumit approved for pulmonary arterial hypertension

First non-hormonal remedy approved for menopausal hot flashes

Pomalyst approved for advanced multiple myeloma

Recommended for you

Antipsychotics for dementia linked to more harms than previously acknowledged

Ketamine produces wide variety of responses in the brain, researchers find

Which treatments for malnutrition's long-term effects could help reduce mortality and health outcomes for children

New drug may slow rapid progression of Parkinson's disease

Large study finds antibiotics aren't effective for most lower tract respiratory infections

Epilepsy drug prevents brain tumors in mice with neurofibromatosis type 1

Newsletter sign up

Donate and enjoy an ad-free experience